DaVita HealthCare Company Insiders

DVA Stock  USD 127.82  1.71  1.36%   
DaVita HealthCare's insiders are aggressively selling. The analysis of insiders' sentiment of trading DaVita HealthCare Partners stock suggests that vertually all insiders are panicking at this time. DaVita HealthCare employs about 70 K people. The company is managed by 42 executives with a total tenure of roughly 305 years, averaging almost 7.0 years of service per executive, having 1666.67 employees per reported executive.
Javier Rodriguez  CEO
Chief Executive Officer, Director
Craig Samitt  CEO
Executive Vice President; CEO of HealthCare Partners

DaVita HealthCare's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-02-26Javier RodriguezDisposed 67603 @ 126.11View
2024-02-21Michael David StaffieriDisposed 29488 @ 119.81View
2024-02-16James O HeartyDisposed 26164 @ 119.64View
2023-12-14Jerry MoranDisposed @ 107.18
2023-12-12Tommy TubervilleDisposed @ 108.48
2023-08-22Kathleen Alyce WatersDisposed 9794 @ 101.81View
2023-06-12Tommy TubervilleDisposed @ 97.09
2023-05-12Phyllis R YaleDisposed 2196 @ 95.26View
2023-05-10Javier RodriguezDisposed 16916 @ 99.44View
Monitoring DaVita HealthCare's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

DaVita HealthCare's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with DaVita HealthCare's future performance. Based on our forecasts, it is anticipated that DaVita will maintain a workforce of about 70000 employees by May 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

DaVita HealthCare's latest congressional trading

Congressional trading in companies like DaVita HealthCare, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in DaVita HealthCare by those in governmental positions are based on the same information available to the general public.
2023-12-14Senator Jerry Moran, Acquired Under $15KVerify
2023-12-12Senator Thomas H TubervilleAcquired Under $15KVerify
2021-12-21Senator Jerry MoranAcquired Under $15KVerify

DaVita HealthCare Management Team Effectiveness

The company has Return on Asset of 0.0592 % which means that on every $100 spent on assets, it made $0.0592 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3853 %, implying that it generated $0.3853 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, DaVita HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.15, whereas Return On Assets are forecasted to decline to 0.04. At present, DaVita HealthCare's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 10.6 B.
The current year's Common Stock Shares Outstanding is expected to grow to about 149.6 M, whereas Net Income Applicable To Common Shares is forecasted to decline to about 491.9 M.

DaVita HealthCare Workforce Comparison

DaVita HealthCare Partners is one of the top stocks in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 84,171. DaVita HealthCare totals roughly 70,000 in number of employees claiming about 83% of equities under Health Care industry.

DaVita HealthCare Profit Margins

The company has Net Profit Margin of 0.06 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.12 %, which entails that for every 100 dollars of revenue, it generated $0.12 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.340.2533
Significantly Up
Slightly volatile
Net Profit Margin0.04710.057
Significantly Down
Pretty Stable
Operating Profit Margin0.170.1319
Significantly Up
Pretty Stable
Pretax Profit Margin0.080.097
Significantly Down
Slightly volatile
Return On Assets0.0350.0392
Fairly Down
Very volatile
Return On Equity0.690.6548
Notably Up
Slightly volatile

DaVita HealthCare Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DaVita HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on DaVita HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DaVita HealthCare insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.2821
11
39
 1,654,608 
 2,989,910 
2023-12-01
3.6667
11
3
 513,154 
 894,297 
2023-09-01
2.25
9
4
 43,800 
 80,000 
2023-06-01
0.5833
21
36
 538,327 
 991,758 
2023-03-01
1.5294
26
17
 174,867 
 42,499 
2022-12-01
10.0
10
1
 10,497 
 602.00 
2022-09-01
8.0
8
1
 3,915 
 0.00 
2022-06-01
0.7692
20
26
 316,943 
 354,617 
2022-03-01
3.6
18
5
 256,996 
 6,894 
2021-12-01
4.0
8
2
 3,229 
 767.00 
2021-09-01
0.9
9
10
 184,815 
 361,881 
2021-06-01
0.52
26
50
 3,374,940 
 4,928,503 
2021-03-01
10.5
21
2
 252,360 
 10,436 
2020-12-01
0.5714
20
35
 149,764 
 322,691 
2020-09-01
1.0
12
12
 46,469 
 4,274,416 
2020-06-01
0.5957
28
47
 256,131 
 620,529 
2020-03-01
2.5
20
8
 3,235,557 
 40,679 
2019-12-01
1.125
9
8
 6,347 
 625,446 
2019-06-01
2.5714
36
14
 556,309 
 28,583 
2018-06-01
1.4444
39
27
 583,857 
 392,495 
2018-03-01
1.0
15
15
 1,242,207 
 2,377,421 
2017-12-01
1.0
15
15
 1,243,021 
 2,304,208 
2017-06-01
1.8421
35
19
 871,367 
 268,093 
2017-03-01
3.25
13
4
 296,604 
 807.00 
2016-12-01
4.3333
13
3
 95,740 
 186,447 
2016-09-01
0.9412
16
17
 64,746 
 113,838 
2016-06-01
1.1563
37
32
 1,149,336 
 1,097,114 
2016-03-01
0.8889
16
18
 422,501 
 900,719 
2015-12-01
1.0
13
13
 1,013,976 
 1,879,603 
2015-09-01
0.7647
13
17
 130,214 
 258,946 
2015-06-01
1.0513
41
39
 854,005 
 603,796 
2015-03-01
0.4054
15
37
 192,130 
 690,598 
2014-12-01
0.8125
26
32
 2,541,634 
 1,676,992 
2014-09-01
1.1111
10
9
 15,067 
 115,114 
2014-06-01
1.0556
38
36
 951,838 
 720,942 
2014-03-01
0.8333
60
72
 3,048,147 
 1,711,379 
2013-12-01
9.1667
55
6
 10,054,599 
 42,864 
2013-09-01
33.0
33
1
 1,619,954 
 0.00 
2013-06-01
2.1333
32
15
 497,454 
 812,410 
2013-03-01
4.8667
73
15
 2,380,421 
 82,500 
2012-12-01
2.6977
116
43
 4,569,362 
 1,215,218 
2012-09-01
0.8333
40
48
 1,377,764 
 2,225,488 
2012-06-01
8.6667
26
3
 102,045 
 18,750 
2012-03-01
1.2593
34
27
 191,683 
 395,704 
2011-12-01
28.0
28
1
 42,517 
 40,000 
2011-09-01
1.4286
20
14
 15,325 
 268,334 
2011-06-01
0.9091
40
44
 1,870,359 
 1,724,906 
2011-03-01
0.641
50
78
 635,741 
 1,303,590 
2010-12-01
0.5465
47
86
 650,838 
 1,328,173 
2010-09-01
2.8889
26
9
 17,377 
 30,000 
2010-06-01
1.1818
26
22
 219,489 
 274,729 
2010-03-01
1.48
37
25
 1,075,182 
 861,459 
2009-12-01
1.5263
29
19
 329,934 
 1,272,801 
2009-09-01
2.125
17
8
 39,317 
 126,016 
2009-06-01
1.625
26
16
 525,546 
 799,420 
2009-03-01
2.375
19
8
 1,451,460 
 272,506 
2008-12-01
2.0
22
11
 231,703 
 486,318 
2008-09-01
0.7931
23
29
 209,684 
 519,229 
2008-06-01
0.2561
21
82
 124,878 
 158,004 
2008-03-01
0.5143
54
105
 1,974,533 
 158,124 
2007-12-01
0.1406
18
128
 294,516 
 660,897 
2007-09-01
0.0846
22
260
 558,855 
 1,281,907 
2007-06-01
0.1732
22
127
 161,060 
 281,377 
2007-03-01
0.5094
27
53
 1,501,246 
 249,500 
2006-12-01
0.1532
19
124
 409,350 
 574,467 
2006-09-01
0.2951
18
61
 1,064,191 
 260,000 
2006-06-01
0.5806
18
31
 142,513 
 89,093 
2006-03-01
0.0754
23
305
 600,033 
 1,292,513 
2005-12-01
0.4444
12
27
 137,379 
 213,822 
2005-09-01
0.4167
20
48
 1,258,428 
 853,544 
2005-06-01
0.3529
24
68
 417,116 
 802,500 
2005-03-01
0.2927
12
41
 485,740 
 985,000 
2004-12-01
1.0667
16
15
 364,784 
 493,026 
2004-09-01
1.0833
13
12
 153,220 
 317,373 
2004-06-01
0.8182
36
44
 448,605 
 846,050 
2004-03-01
0.5391
62
115
 1,185,107 
 1,089,935 
2003-12-01
0.4459
33
74
 469,446 
 924,645 
2003-09-01
0.3548
11
31
 124,064 
 216,000 
2003-06-01
1.1667
7
6
 88,000 
 63,000 

DaVita HealthCare Notable Stakeholders

A DaVita HealthCare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DaVita HealthCare often face trade-offs trying to please all of them. DaVita HealthCare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DaVita HealthCare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Javier RodriguezChief Executive Officer, DirectorProfile
Craig SamittExecutive Vice President; CEO of HealthCare PartnersProfile
Dennis KogodCEO of International and President of Healthcare PartnersProfile
Robert MargolisCo-Chairman of the BoardProfile
Pamela ArwayIndependent Chairman of the BoardProfile
Kent ThiryChairman, CEO and CEO of Healthcare PartnersProfile
Robert LangPresident International BusinessProfile
Jim GustafsonVice President - Investor RelationsProfile
Atul MathurExecutive Vice President of Global OperationsProfile
LeAnne ZumwaltGroup Vice President - purchasing and government affairsProfile
James HilgerInterim CFO and Chief Accounting OfficerProfile
Joel AckermanChief Financial Officer, TreasurerProfile
Joseph MelloCOO of HealthCare PartnersProfile
Michael StaffieriChief Operating Officer- DaVita Kidney CareProfile
Paul DiazIndependent DirectorProfile
John NehraIndependent DirectorProfile
Peter GrauerLead Independent DirectorProfile
Phyllis YaleIndependent DirectorProfile
Roger ValineIndependent DirectorProfile
Pascal DesrochesIndependent DirectorProfile
Carol DavidsonIndependent DirectorProfile
Barbara DesoerIndependent DirectorProfile
William RoperIndependent DirectorProfile
Charles BergIndependent DirectorProfile
James HeartyChief Compliance OfficerProfile
Shawn GuertinDirectorProfile
Paula PriceIndependent DirectorProfile
Misha PalecekChief BusinessProfile
Christopher BerryGroup OfficerProfile
Jeffrey GiullianChief CareProfile
John WinstelChief Accounting Officer, Group Vice PresidentProfile
Kenneth SmithChief OfficerProfile
Gregory MooreIndependent DirectorProfile
David RoerChief Medical Officer - DaVita Integrated Kidney CareProfile
FRCPC MDChief OperationsProfile
Kathleen WatersChief Legal and Public Affairs OfficerProfile
Kenny GardnerChief People Officer - DaVita Kidney CareProfile
Kim RiveraChief Legal OfficerProfile
Mihran NaljayanChief Medical Officer - Home ModalitiesProfile
Jeanine JigantiChief Compliance OfficerProfile
Laura MildenbergerChief People Officer - Kidney CareProfile
MSc MDChief InternationalProfile

About DaVita HealthCare Management Performance

The success or failure of an entity such as DaVita HealthCare often depends on how effective the management is. DaVita HealthCare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DaVita management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DaVita management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.07 
Return On Capital Employed 0.11  0.15 
Return On Assets 0.04  0.04 
Return On Equity 0.65  0.69 
The data published in DaVita HealthCare's official financial statements usually reflect DaVita HealthCare's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of DaVita HealthCare. For example, before you start analyzing numbers published by DaVita accountants, it's critical to develop an understanding of what DaVita HealthCare's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of DaVita HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DaVita HealthCare's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in DaVita HealthCare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DaVita HealthCare Partners. Please utilize our Beneish M Score to check the likelihood of DaVita HealthCare's management manipulating its earnings.

DaVita HealthCare Workforce Analysis

Traditionally, organizations such as DaVita HealthCare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DaVita HealthCare within its industry.

DaVita HealthCare Manpower Efficiency

Return on DaVita HealthCare Manpower

Revenue Per Employee173.4K
Revenue Per Executive289.1M
Net Income Per Employee9.9K
Net Income Per Executive16.5M
Working Capital Per Employee7.1K
Working Capital Per Executive11.8M
When determining whether DaVita HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DaVita HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Davita Healthcare Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Davita Healthcare Partners Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for DaVita Stock analysis

When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is DaVita HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.2
Earnings Share
7.42
Revenue Per Share
133.717
Quarterly Revenue Growth
0.078
Return On Assets
0.0592
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.